The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis
Angus DC, Laterre PF, Elterbrand J, et al. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Critical Care Medicine. 2004;32(11):2199-2206.
This article reports that patients who receive drotrecogin alfa (activated) therapy during severe sepsis have increased survival rates through hospital discharge, though the benefit does not persist past discharge.
|
This item has not yet been rated
|
 |
View article abstract
|
